Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Mar;27(3):478–484.

Cellular immunity in newborn infants and children: stimulation of lymphocyte protein synthesis as a measure of immune competence.

B Schechter, Z T Handzel, Y Altman, E Nir, S Levin
PMCID: PMC1540926  PMID: 862234

Abstract

An assay based on the early stimulation of protein synthesis in lymphocytes has been used as an in vitro measure of cellular immune competence. 3H-labelled leucine incorporation into human peripheral lymphocytes (PBL) stimulated by the mitogens phytohaemagglutinin (PHA), wax bean agglutinin (WBA) and Concanavalin A (Con A) was measured after one day in culture. This assay offers a technical advantage over the analogous 3H-labelled thymidine incorporation assay, because of the short incubation time required and the absence of homologous serum in the assay system. Newborn infants and patients with Down's syndrome as a group had normal responses, whereas those suffering from recurrent infections demonstrated normal or hyper-reactive responses. Patients with lymphoproliferative disorders, ataxia telangiectasia, and some patients under steroid therapy had diminished immune proliferative reactions. These results are in agreement with most previously reported studies using other assay systems.

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adkinson N. F., Jr, Rosenberg S. A., Terry W. D. Early detection of lymphocyte stimulation and mixed lymphocyte interaction in man with a semimicro protein synthesis assay. J Immunol. 1974 Apr;112(4):1426–1434. [PubMed] [Google Scholar]
  2. Agarwal S. S., Blumberg B. S., Gerstley B. J., London W. T., Sutnick A. I., Loeb L. A. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome. J Clin Invest. 1970 Jan;49(1):161–169. doi: 10.1172/JCI106215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRAUN P., REITMAN N., FLORIN A. A. CLOSED-CHEST CARDIAC RESUSCITATION. PROBLEMS IN THE TRAINING OF LAYMEN IN VOLUNTEER RESCUE SQUADS. N Engl J Med. 1965 Jan 7;272:1–6. doi: 10.1056/NEJM196501072720101. [DOI] [PubMed] [Google Scholar]
  4. Burgio G. R., Ugazio A. G., Nespoli L., Marcioni A. F., Bottelli A. M., Pasquali F. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur J Immunol. 1975 Sep;5(9):600–603. doi: 10.1002/eji.1830050904. [DOI] [PubMed] [Google Scholar]
  5. Gorczynski R. M., Rittenberg M. B. Stimulation of early protein synthesis as an assay of immune reactivity: analysis of the cells responding to mitogens and alloantigens. J Immunol. 1974 Jan;112(1):47–55. [PubMed] [Google Scholar]
  6. HIRSCHHORN K., BACH F., KOLODNY R. L., FIRSCHEIN I. L., HASHEM N. IMMUNE RESPONSE AND MITOSIS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO. Science. 1963 Nov 29;142(3596):1185–1187. doi: 10.1126/science.142.3596.1185. [DOI] [PubMed] [Google Scholar]
  7. Hahn T., Levin S., Handzel Z. T. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency. Clin Exp Immunol. 1976 Jun;24(3):448–454. [PMC free article] [PubMed] [Google Scholar]
  8. Hayakawa H., Matsui I., Higurashi M., Kobayashi N. Hyperblastic response to dilute P.H.A. in Down's syndrome. Lancet. 1968 Jan 13;1(7533):95–96. doi: 10.1016/s0140-6736(68)90109-8. [DOI] [PubMed] [Google Scholar]
  9. Kersey J. H., Gajl-Peczalska K. J., Nesbit M. E. The lymphoid system: abnormalities in immunodeficiency and malignancy. J Pediatr. 1974 Jun;84(6):789–796. doi: 10.1016/s0022-3476(74)80749-3. [DOI] [PubMed] [Google Scholar]
  10. Levin S., Nir E., Mogilner B. M. T system immune-deficiency in Down's syndrome. Pediatrics. 1975 Jul;56(1):123–126. [PubMed] [Google Scholar]
  11. Levy R., Kaplan H. S. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974 Jan 24;290(4):181–186. doi: 10.1056/NEJM197401242900402. [DOI] [PubMed] [Google Scholar]
  12. Levy R., Rosenberg S. A. The early stimulation of protein synthesis in sensitized guinea pig lymph node cells by antigen. J Immunol. 1972 Apr;108(4):1073–1079. [PubMed] [Google Scholar]
  13. McFarlin D. E., Oppenheim J. J. Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. J Immunol. 1969 Dec;103(6):1212–1222. [PubMed] [Google Scholar]
  14. Mendelsohn J., Skinner A., Kornfeld S. The rapid induction by phytohemagglutinin of increased alpha-aminoisobutyric acid uptake by lymphocytes. J Clin Invest. 1971 Apr;50(4):818–826. doi: 10.1172/JCI106553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Oppenheim J. J., Barlow M., Waldmann T. A., Block J. B. Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis. Br Med J. 1966 Aug 6;2(5509):330–333. doi: 10.1136/bmj.2.5509.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. PETERSON R. D., KELLY W. D., GOOD R. A. ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY. Lancet. 1964 May 30;1(7344):1189–1193. doi: 10.1016/s0140-6736(64)91209-7. [DOI] [PubMed] [Google Scholar]
  17. Rosenberg S. A., Levy R., Schechter B. A rapid microassay of cellular immunity in the guinea pig and mouse. Transplantation. 1972 May;13(5):541–545. doi: 10.1097/00007890-197205000-00017. [DOI] [PubMed] [Google Scholar]
  18. Schechter B., Lis H., Lotan R., Novogrodsky A., Sharon N. The requirement for tetravalency of soybean agglutinin for induction of mitogenic stimulation of lymphocytes. Eur J Immunol. 1976 Mar;6(3):145–149. doi: 10.1002/eji.1830060302. [DOI] [PubMed] [Google Scholar]
  19. Schumann G., Schnebli H. P., Dukor P. Selective stimulation of mouse lymphocyte populations by lectins. Int Arch Allergy Appl Immunol. 1973;45(3):331–340. doi: 10.1159/000231051. [DOI] [PubMed] [Google Scholar]
  20. Szigeti R., Révész T., Schuler D. Cell-mediated immune response in patients with Down's syndrome. Acta Paediatr Acad Sci Hung. 1974;15(1):31–39. [PubMed] [Google Scholar]
  21. Wells J. V., Fudenberg H. H. Management of patients with primary immune deficiency syndromes. Aust N Z J Med. 1974 Aug;4(4):396–411. doi: 10.1111/j.1445-5994.1974.tb03211.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES